中国老年保健医学Issue(6)：44-45,46,3.DOI:10.3969/j.issn.1672-4860.2014.06.019
左西孟旦治疗高龄老年终末期心力衰竭疗效评价
End-stage heart failure efficacy of levosimendan in the treatment of the elderly
刘召红 1贺仙光1
作者信息
- 1. 解放军第107中心医院 高干科 264002
- 折叠
摘要
Abstract
Objectives To observe the effect of levosimendan in the treatment of elderly patients with end-stage heart failure clinical efficacy and safety.Methods 56 cases of senile heart failure patients meet the inclusion criteria were randomly divided into routine treatment group and levosimendan and conventional therapy group.To observe the clinical efficacy of the two groups before and after treatment,the heart function,the determination of NT-proBNP,SV,LVEF and other indicators,and security analysis.Re-sults The levosimendan group of significant efficiency,efficiency and total effective rate were higher than normal group(P<0.05);levosimendan treatment in reducing NT-proBNP,improved SV,LVEF is obviously superior to the conventional treatment group( P<0.05),adverse reactions of two groups was no significant difference(P>0.05),no serious adverse events,the most common adverse events are hypotension,anorexia,dizziness.Conclusions levosimendan in the treatment of elderly patients with end-stage heart fail-ure,can significantly improve the hemodynamics,improve heart function,improve the symptoms of heart failure,good safety and toler-ability.关键词
左西孟旦心力衰竭/高龄Key words
Levosimendan/heart failure in elderly引用本文复制引用
刘召红,贺仙光..左西孟旦治疗高龄老年终末期心力衰竭疗效评价[J].中国老年保健医学,2014,(6):44-45,46,3.
